Mammalian target of rapamycin as a therapeutic target in osteoporosis
Lists
Only you see this
Abstract
The mechanistic target of rapamycin (mTOR) plays a key role in sensing and integrating large amounts of environmental cues to regulate organismal growth, homeostasis, and many major cellular processes. Recently, mounting evidences highlight its roles in regulating bone homeostasis, which sheds light on the pathogenesis of osteoporosis. The activation/inhibition of mTOR signaling is reported to positively/negatively regulate bone marrow mesenchymal stem cells (BMSCs)/osteoblasts-mediated bone formation, adipogenic differentiation, osteocytes homeostasis, and osteoclasts-mediated bone resorption, which result in the changes of bone homeostasis, thereby resulting in or protect against osteoporosis. Given the likely importance of mTOR signaling in the pathogenesis of osteoporosis, here we discuss the detailed mechanisms in mTOR machinery and its association with osteoporosis therapy.
BibTeX
@article{shen2017mammalian,
author = {Gengyang Shen and Hui Ren and Ting Qiu and Wenchao Zhang and Wenhua Zhao and Xiang Yu and Jinjing Huang and Jingjing Tang and De Liang and Zhensong Yao and Zhidong Yang and Xiaobing Jiang},
title = {{Mammalian target of rapamycin as a therapeutic target in osteoporosis}},
journal = {Journal of Cellular Physiology},
year = {2017},
doi = {10.1002/jcp.26161},
}Loading related content...